The Blog

VeraSci is now offering the Placebo Control Reminder Script through the Pathway eCOA system

Placebo response is a potentially devastating component of CNS trials, particularly those with subjective patient-reported outcomes and high levels of interaction with clinical staff. In pain, depression, and other psychiatric studies using subjective primary endpoints, high placebo rates contribute substantially to the late-stage failure of promising treatments. VeraSci is now offering a scientifically-backed instrument, the…

Read More

New Schizophrenia Publication Co-Authored by Dr. Walling

Check out a new publication co-authored by David Walling, Ph.D., Chief Executive Officer and Principal Investigator at CNS Research. Efficacy and safety of a 2-month formulation of aripiprazole lauroxil with 1-day initiation in patients hospitalized for acute schizophrenia transitioned to outpatient care: phase 3, randomized, double-blind, active-control ALPINE study. J Clin Psychiatry. 2020;81(3):19m13207. https://doi.org/10.4088/JCP.19m13207  

Read More

Armen Goenjian, M.D., Discusses Treating Psychological Problems After Catastrophic Disasters in Interview for Psychology Today

Dr. Armen Goenjian, Chief Medical Officer and Principal Investigator at CNS Research, discussed his humanitarian work and post-disaster research with Jamie D. Aten Ph.D., the Founder and Executive Director of the Humanitarian Disaster Institute at Wheaton College.   JA: How did you first get interested in this topic? AG: It goes back to December 7,…

Read More

Apex Sites Present Poster on Placebo-Control Reminder Script at ASCP

Apex Sites Present Poster on Placebo-Control Reminder Script at ASCP Hassman Research Institute and CNS Research, collectively Apex Innovative Sciences, continue to study the Placebo-Control Reminder Script (PCRS), which methodically reviews with subjects the commonly-cited crucial causes of placebo response, in an effort to explore direct strategies for reducing the insidious placebo and nocebo effects…

Read More

Neurana Pharmaceuticals Announces Publication of a Driving Study Conducted by CNS Research

May 12, 2020 — Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced the publication of a driving study which demonstrates the tolerability and safety of tolperisone in the peer-reviewed Journal of Clinical Pharmacy and Therapeutics. The publication, “An assessment of the centrally acting muscle relaxant tolperisone on…

Read More

CoVlD-19 (Coronavirus): Risk Mitigation & Response Plans

CoVlD-19 (Coronavirus): Risk Mitigation & Response Plans   APEX COVID-19 Response Documents   As our communities battle COVID-19, CNS Research and Hassman Research Institute, now collectively Apex Innovative Sciences, remain committed to upholding our promises to you in the conduct of your trials and all sites remain open and actively screening new subject and conducting…

Read More

CNS Research Praised for Excellent Work Under Difficult Circumstances

Good news is appreciated at this difficult time. Here’s what our CNS Research site got from one of our sponsors today: I will say that we are all very impressed with the site’s professionalism during this very challenging time.  Their professionalism is remarkable and noted through our organization.  As a former health care provider (I…

Read More

What You Need To Know About Handwashing

This video answers important questions about hand washing and hand sanitizer. 

Read More

COVID-19 Action Updates

    COVID-19 Action Updates Please know that our Executive Management Team, our Chief Compliance Officer and all Apex staff are taking subject and employee safety seriously. Below are some measures we’ve taken, with new initiatives daily as needed to address an evolving situation. Apex leadership has shared best practices for dealing with this crisis…

Read More

CNS Network and Hassman Research Institute Complete Strategic Merger

  CNS Network and Hassman Research Institute Complete Strategic Merger to Form Apex Innovative Sciences, Inc.   Marlton, NJ and Garden Grove, CA (October 1, 2019). CNS Network (“CNS”) and Hassman Research Institute (“HRI”) have completed a strategic merger to form Apex Innovative Sciences, Inc. (“Apex” or the “Company”). The combination represents the industry leading…

Read More
Page 1 of 1012 »